- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07627139
Metacognitive Bibliotherapy for Anxiety, Depression, and Metacognitions in University Students
The Effects of a Metacognitive Bibliotherapy Intervention on Anxiety, Depression, and Metacognitions Among University Students: A Randomized Controlled Trial
The goal of this clinical trial is to learn if a self-help reading program, called metacognitive bibliotherapy, can reduce anxiety and depression in university students studying medicine and health sciences. It will also examine whether the program changes unhelpful thinking patterns about worry and rumination.
The main questions it aims to answer are:
Does metacognitive bibliotherapy lower anxiety and depression symptoms in university students? Does it reduce unhelpful thinking patterns, such as excessive worry and rumination?
Researchers will compare two different self-help books with a waiting list group to see if reading these books helps reduce anxiety and depression.
Participants will:
- Be randomly assigned to one of three groups: read The Art of Letting Go - How to Stop Rumination, read Anchored: How to Befriend Your Nervous System Using Polyvagal Theory, or join a waiting list
- Read the assigned book at their own pace over 8 weeks
- Complete online questionnaires at the start of the study, after 4 weeks, and after 8 weeks
- Participants in the waiting list group will receive both books for free after the 8-week study period ends
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Background and Rationale Medical and health sciences students represent a high-risk subgroup for anxiety and depressive symptoms due to intense academic demands and clinical responsibilities. Current literature indicates that the Cognitive Attentional Syndrome (CAS) - a transdiagnostic mechanism encompassing perseverative worry, rumination, threat monitoring, and maladaptive coping strategies - plays a central mediating role in the transition from academic stress to clinical psychopathology. Low-intensity, structured self-help bibliotherapy offers an accessible, cost-effective, and scalable intervention that may support self-regulation capacity in at-risk student populations.
Objective This randomized controlled trial aims to evaluate the therapeutic efficacy of structured bibliotherapy on anxiety, depression, and metacognitive beliefs in university students studying medicine and health sciences.
Study Design
A three-arm randomized controlled trial will be conducted with 110 participants. Sample size was determined through G*Power analysis (α = 0.05, power = 80%), with at least 30 participants per group and an allowance for dropout. Participants will be allocated to one of three groups using computer-based block randomization:
Group 1: Receives the self-help book "The Art of Letting Go - How to Stop Rumination" as a structured, low-intensity bibliotherapy material Group 2: Receives the self-help book "Anchored: How to Befriend Your Nervous System Using Polyvagal Theory" as a structured, low-intensity bibliotherapy material Waiting List Control Group: Receives no intervention during the study period; after the 8-week data collection is complete, participants may obtain both self-help books free of charge.
Participants and Setting The study population consists of students enrolled in health sciences programs at Istanbul Nişantaşı University. Participants will be recruited through voluntary convenience sampling.
Inclusion Criteria: Active enrollment in the specified faculties; voluntary informed consent.
Exclusion Criteria: Currently receiving active psychiatric treatment (psychotherapy or pharmacotherapy); change in psychopharmacological medication within the past 6 months; prior reading of the study books; presence of acute psychotic symptoms or suicidal risk.
Intervention Participants in the experimental groups receive the assigned book free of charge and are asked to read it at their own pace over an 8-week guided bibliotherapy period.
Outcome Measures
Data will be collected via online self-report questionnaires at three time points: baseline (Week 0), mid-intervention (Week 4), and post-intervention (Week 8). The following validated instruments will be used:
Cognitive Attentional Syndrome Scale (CAS-1): to assess perseverative thinking and threat monitoring
Metacognitions Questionnaire-30 (MCQ-30): to evaluate metacognitive beliefs
Depression Anxiety Stress Scales-21 (DASS-21): to measure the severity of depression, anxiety, and stress symptoms
Statistical Analysis Data will be analyzed using repeated measures ANOVA to examine between-group differences and within-group changes over time. Intent-to-treat principles will be applied to address missing data.
Ethical Considerations The study was approved by the Istanbul Nişantaşı University Health Sciences Ethics Committee (Approval No: 2026.04.10, dated 14.04.2026). All participants will provide digital informed consent and may withdraw at any time without consequence. Participant data will be anonymized and stored securely. Participants showing high-risk indicators will be referred to appropriate psychological support services.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Alişan Burak Yaşar, MD, Assoc. Prof.
- Número de telefone: +90 532 424 30 58
- E-mail: alisanburak.yasar@nisantasi.edu.tr
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
- Active enrollment in the Faculties of Medicine, Nursing, Pharmacy, Dentistry, or Psychology at Istanbul Nisantasi University
- Aged between 18 and 25 years
- Provision of voluntary digital informed consent
Exclusion Criteria:
- Currently receiving active psychiatric treatment (psychotherapy or pharmacotherapy)
- Change in psychopharmacological medication within the past 6 months
- Prior reading of either of the study books
- Presence of acute psychotic symptoms or suicidal risk
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Prevenção
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Bibliotherapy - Group 1
Participants in this group receive the self-help book "The Art of Letting Go - How to Stop Rumination" as a structured, low-intensity bibliotherapy material.
Participants are asked to read the book at their own pace over an 8-week guided bibliotherapy period.
The book is provided free of charge.
|
A structured, low-intensity self-help reading program.
Participants assigned to Experimental Group 1 receive this self-help book free of charge and read it at their own pace over an 8-week guided bibliotherapy period.
|
|
Sem intervenção: Waiting List Control
Participants in this group receive no intervention during the 8-week study period.
They complete the same online assessments at baseline (Week 0), mid-intervention (Week 4), and post-intervention (Week 8) as the intervention groups.
After the 8-week data collection is complete, participants in this group will receive both self-help books free of charge, in accordance with the ethical principle of waiting-list compensation.
|
|
|
Experimental: Bibliotherapy - Group 2
Participants in this group receive the self-help book "Anchored" as a structured, low-intensity bibliotherapy material.
Participants are asked to read the book at their own pace over an 8-week guided bibliotherapy period.
Self-report assessments are completed at baseline (Week 0), mid-intervention (Week 4), and post-intervention (Week 8).
The book is provided free of charge.
|
A structured, low-intensity self-help reading program.
Participants assigned to Group 2 receive this self-help book free of charge and read it at their own pace over an 8-week guided bibliotherapy period.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in Depression, Anxiety, and Stress Symptoms (DASS-21)
Prazo: Baseline (Week 0), mid-intervention (Week 4), and post-intervention (Week 8)
|
Depression, anxiety, and stress symptom severity will be measured using the Depression Anxiety Stress Scales-21 (DASS-21), a validated self-report instrument.
Higher scores indicate greater symptom severity.
Change will be assessed across the three measurement points.
|
Baseline (Week 0), mid-intervention (Week 4), and post-intervention (Week 8)
|
|
Change in Metacognitive Beliefs (MCQ-30)
Prazo: Baseline (Week 0), mid-intervention (Week 4), and post-intervention (Week 8)
|
Metacognitive beliefs will be measured using the Metacognitions Questionnaire-30 (MCQ-30), a validated self-report instrument.
Higher scores indicate stronger maladaptive metacognitive beliefs.
Change will be assessed across the three measurement points.
|
Baseline (Week 0), mid-intervention (Week 4), and post-intervention (Week 8)
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in Cognitive Attentional Syndrome (CAS-1)
Prazo: Baseline (Week 0), mid-intervention (Week 4), and post-intervention (Week 8)
|
The Cognitive Attentional Syndrome Scale (CAS-1) will be used to assess perseverative thinking (worry and rumination), threat monitoring, and maladaptive coping strategies.
Higher scores indicate greater engagement in the cognitive attentional syndrome.
Change will be assessed across the three measurement points.
|
Baseline (Week 0), mid-intervention (Week 4), and post-intervention (Week 8)
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 2026.04.10 (Outro identificador: Istanbul Nisantasi University Health Sciences Ethics Committee)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .